ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO955

Contribution of Proximal Tubular Solute Clearance in Residual Kidney Function

Session Information

Category: Dialysis

  • 703 Dialysis: Peritoneal Dialysis

Authors

  • Wang, Ke, University of Washington, Seattle, Washington, United States
  • Nguyen, Michelle Huyen, Kidney Research Institute, Seattle, Washington, United States
  • Kundzins, John R., University of Washington, Seattle, Washington, United States
  • Goodling, Anne, Kidney Research Institute, Seattle, Washington, United States
  • Chen, Yan, University of Washington, Seattle, Washington, United States
  • Zelnick, Leila R., Kidney Research Institute, Seattle, Washington, United States
  • Hoofnagle, Andrew N., University of Washington, Seattle, Washington, United States
  • Kestenbaum, Bryan R., University of Washington, Seattle, Washington, United States
Background

Residual kidney function (RKF) is associated with better health outcomes in end-stage kidney disease (ESKD). Current assessment of RKF relies on creatinine and urea clearance to estimate the glomerular filtration rate. Proximal tubular secretion is an essential intrinsic kidney function that is rarely measured in ESKD. We measured the kidney and peritoneal clearances of tubular secretory solutes in a primary cohort of incident peritoneal dialysis (PD) patients and determined association with uremic symptoms.

Methods

We enrolled 29 incident PD patients with RKF. We used liquid chromatography-mass spectrometry to quantify plasma, 24-hour urine, and dialysate concentrations of ten tubular secretory solutes. We calculated the kidney and peritoneal dialysis clearances of secretory solutes, creatinine, and urea standardized to 1.73m2. We created a composite secretory clearance score as the average of each solute clearance. We assessed symptom severity using the Dialysis Symptom Index.

Results

The mean age of our cohort was 55 years, mean dialysis duration was 4 months, and mean GFRurea+Cr was 7.8 mL/min/1.73m2. The kidney clearances of secretory solutes ranged from 1.3 ml/min/1.73m2 for p-cresol sulfate to 94.6 ml/min/1.73m2 for hippurate (Table). The residual kidney clearance of each secretory solute was substantially higher than peritoneal dialysis clearance. Worse dialysis symptom severity was correlated with a lower composite secretory clearance score (r= -0.46; p=0.01) and, to a lesser extent, lower GFRurea+Cr (r= -0.35; p=0.06).

Conclusion

Among incident PD patients, tubular secretory solutes are more avidly cleared by residual kidney function than peritoneal clearance. Secretory solute clearance correlates more strongly with the severity of uremic symptoms compared with GFRurea+Cr.

Funding

  • NIDDK Support